HomeREGULATORY
REGULATORY

Celgene Faces Biz Improvement Order over Delays in Side Effect Reporting
(Mar.15.2017)

The Ministry of Health, Labor and Welfare (MHLW) issued a business improvement order to Celgene on March 14 over a violation of reporting requirements related to over 4,500 possible side effect cases involving Revlimid (lenalidomide) and two other drugs ...
(LOG IN FOR FULL STORY)

News Calendar